home · filing · 0001683168-23-007830
8-K filed November 9, 2023, 6:59 PM ET
ticker PMCB
CIK 0001157075
other
confidence high
sentiment neutral
materiality 0.20
PharmaCyte Biotech, Inc. (PMCB): auditor change — PharmaCyte Biotech engages Marcum LLP as new independent auditor after Armanino resignation
PharmaCyte Biotech, Inc.
Armanino resigned as independent auditor on August 1, 2023, citing exit from public company audit practice.
Marcum LLP was engaged as new independent registered public accounting firm on November 5, 2023.
No disagreements or reportable events occurred with Armanino during the past two fiscal years or subsequent period.
Company had not consulted Marcum on accounting principles or audit opinions prior to engagement.
Key facts
Extracted from this filing and checked against the source text.
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
PharmaCyte Biotech, Inc. engaged Marcum LLP as its auditor.
Action engagement
Auditor Marcum LLP
Exact text from the filing
On November 5, 2023, the Company engaged Marcum LLP (“Marcum”) as its new independent registered public accounting firm
View on SEC.gov
Source: SEC EDGAR
accession 0001683168-23-007830
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.